Support- professional: other

Ended Awarded Jul 1, 2016 Last action Jun 14, 2022

Contract number: HHSN261201600016I
Awardee: Battelle Memorial Institute UEI ZFX8JGFQ89F4
Awarding agency: National Cancer Institute National Institutes of Health, Department of Health and Human Services
Task orders: 3 $366,092 obligated

Award facts

Opportunity: N02CM4700142 Solicitation number

Preclinical toxicology of drugs developed for cancer patients Award Notice · Posted Apr 4, 2014
Combined order value: $366,092 Current and potential, with all options
Last date to order 100% complete: Jun 30, 2021
IDV ceiling 2% used: $19,000,000.00
Award type: Multiple award
Who can order: Only the awarding agency
NAICS code: 541690 Other Scientific and Technical Consulting Services
PSC: R499 Support- Professional: Other
Set-aside: No set-aside
Competition: Full and Open Competition · 6 offers Negotiated Proposal / Quote
Pricing: Order Dependent (IDV only)
Legislative mandates: Service Contract Act FAR subpart 22.10

Award details come from SAM.gov/FPDS.

Task order	Ordering agency	Obligated	Awarded
Next MCL-1 NX232-108-172-001 to#3 exploratory TOX study in dogs admin MCL-1 inhibitor orally, 8/1/17-6/30/19… HHSN26100003	National Cancer Institute (NIH)	$116,039	Aug 11, 2017
Next project IDH1_2-pyridinone to#2 characterization of TOX of potential anticancer compounds following multiple dose… HHSN26100002	National Cancer Institute (NIH)	$248,269	Jan 25, 2017
Initial administrative charges to#1 pre-clin TOX study of drug DEV for cancer patients HHSN261201600016I DTP-16-040 TPB HHSN26100001	National Cancer Institute (NIH)	$1,784	Jul 1, 2016

Action	Obligated	Date
Other Administrative Action P00003 · Preclinical toxicology of drugs developed for cancer patients 07/01/2016 - 06/30/2021 MOD to change key personnel	$0	Jun 14, 2022
Other Administrative Action 2 · 07/01/2016 - 06/30/2021MOD to change key personnel	$0	Apr 5, 2017
Other Administrative Action 1	$0	Feb 3, 2017
Original award	$0	Jul 1, 2016

HHSN261201600016I was awarded to Battelle Memorial Institute by National Cancer Institute (National Institutes of Health) on July 1, 2016.

Orders under HHSN261201600016I have obligated $366,092. HHSN261201600016I's own ceiling is $19,000,000.

3 orders have been placed under HHSN261201600016I, the latest on August 11, 2017.

HHSN261201600016I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Yes. HHSN261201600016I is part of Toxicology of Drugs Developed for Cancer Patients.

The extent of competition for HHSN261201600016I was full and open competition. The government received 6 offers.

On GovTribe

Try for free Login